Silexion Therapeutics Corp ‘s stock market performance has been somewhat erratic.
52-week price history of SLXN Stock
A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Silexion Therapeutics Corp’s current trading price is -97.90% away from its 52-week high, while its distance from the 52-week low is 37.68%. The stock’s price range during this period has spanned from $0.21 to $13.56. In the Healthcare sector, the Silexion Therapeutics Corp’s shares surpassed a trading volume of approximately 0.95 million for the day, which was noticeably lower compared to the average daily volume of 9.5.89 million over the past three months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Market Capitalization and Financial Performance: An In-Depth Look
Silexion Therapeutics Corp (SLXN) has experienced a quarterly decline of -81.73% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 4.11M.
Making Sense of Trading Volume and Moving Average Data
Examining SLXN’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for SLXN stands at 1.32. Similarly, the long-term debt-to-equity ratio is also 0.00.
SLXN Stock Stochastic Average
Today, Silexion Therapeutics Corp’s raw stochastic average for the past 50 days stands at 11.26%, indicating a decline from the raw stochastic average of the last 20 days, which was 30.14%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 37.55% and 39.45% respectively.
SLXN Stock Price Performance Analysis
Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. The metric has seen a significant loss of -97.37% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -97.37%. Over the past 30 days, the price of SLXN has leaped by -3.65%. And in the last five days, it has fallen by -14.44%.
